 |
인쇄하기
취소
|
Bufexamac-containing medicines to be banned
The Korea Food and Drug Administration (KFDA) said on December 8 it has decided to ban sales of controversial bufexamac-based drugs, because of high risk of contact allergies.
Bufexamac is a non-steroidal anti-inflammatory drug (NSAID), used as topical formulations to treat dermatological diseases (eczema and dermatitis) and proctological conditions (hemorrhoids and anal fissure).
The ban...
Bufexamac is a non-steroidal anti-inflammatory drug (NSAID), used as topical formulations to treat dermatological diseases (eczema and dermatitis) and proctological conditions (hemorrhoids and anal fissure).
The ban...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.